HT-2157

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHT-2157
Drug Alias NameHT-2157SNAP-37889
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGalanin receptor 3 antagonists
TargetsGalanin receptor 3
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDart Neuroscience LlcH. Lundbeck A/S
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksWikipedia